| Literature DB >> 2995669 |
J W Watthey, J L Stanton, M Desai, J E Babiarz, B M Finn.
Abstract
Syntheses of the potent angiotensin converting enzyme inhibitor (3S)-1-(carboxymethyl)-3-[[(1S)-1-carboxy-3-phenylpropyl]amino]- 2,3,4,5-tetrahydro-1H-[1]benzazepin-2-one (4b; CGS 14831) and the related monoester prodrug (17a; CGS 14824A) are described together with preparative details for six- and eight-membered ring analogues. Inhibitory potencies and in vivo biological activity of the compounds are discussed. The data indicate that 17a has a biological profile comparable to that of enalapril.Entities:
Mesh:
Substances:
Year: 1985 PMID: 2995669 DOI: 10.1021/jm00148a023
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446